Juan Francisco Hernández, general manager of Latin America at Wockhardt, showcases the added value of the company to the entire region based on quality, safety and cost-effective medicines targeting diabetes, CNS and anti-infective areas.
Could you introduce yourself to our international readers as well as the key activities and operations of Wockhardt in Mexico?
"[Pharmaceutical industry] growth is going to be supported by the increasing role of generics and the national public healthcare system needs cost effective drugs to cover as many patients as possible."
